Last updated on August 6th, 2021 at 06:15 pm
Krsnaa Diagnostics Limited IPO Subscription Status
What is the subscription status for Krsnaa Diagnostics Limited IPO?
[su_table]
Subscription Status {no. of times (x)} | ||||
Particulars | Shares Offered | 4th Aug | 5th Aug | 6th Aug |
QIB | 37,52,625 | 0.48 | 0.50 | 49.83 |
NII | 18,76,312 | 0.15 | 4.70 | 116.30 |
Retail | 12,50,874 | 9.59 | 21.53 | 41.81 |
Employees | 2,32,288 | 0.21 | 0.50 | 0.98 |
Total | 71,12,099 | 1.98 | 5.31 | 64.36 |
[/su_table]
How much is the retail category subscribed?
The retail category is subscribed by 41.81x on the last day of the offer.
What is the GMP of Krsnaa Diagnostics Limited IPO?
The GMP of Krsnaa Diagnostics Limited IPO was Rs 450 per share in the grey market.
How much amount is raised from the anchor investors?
Krsnaa Diagnostics Limited has mobilized Rs 537 crore from the anchor investors ahead of its IPO.
Who are the anchor investors of Krsnaa Diagnostics Limited IPO?
Marquee investors who participated in the anchor book were Kuber India Fund, Volrado Venture Partners, HSBC, Tara Emerging Asia Liquid Fund, Societe Generale, Elara India Opportunities Fund, Nomura, Stock Mother Fund, and Segantii India Mauritius.
Abakkus Growth Fund, ICICI Prudential, HDFC Life Insurance, SBI Mutual Fund, Tata Mutual Fund, Motilal Oswal Mutual Fund, Edelweiss, Nippon Life, Aditya Birla Sun Life, Kotak Mutual Fund, Max Life Insurance, and Kotak Mahindra Life Insurance were the domestic investors who participated in the anchor book.
When will the shares be credited to the Demat account?
Important Dates of Krsnaa Diagnostics Limited IPO
[su_table]
IPO Allotment and Listing | |
Basis of Allotment | 11-Aug-21 |
Refunds | 12-Aug-21 |
Credit to Demat Account | 13-Aug-21 |
Listing Date | 17-Aug-21 |
[/su_table]
All you want to know about IPO Process
- One MobiKwik Systems Limited, MobiKwik IPO - 14/10/2021
- Bharti Airtel Rights Issue- Should You Subscribe? - 07/10/2021
- How to Check your IPO Allotment status? - 28/09/2021
Disclaimer: The above content is for general info purpose only and does not constitute professional advice. The author/ website will not be liable for any inaccurate / incomplete information and any reliance you place on the content is strictly at your risk.
Follow us on Social Media by clicking below
Follow @financepost_in
Be the first to comment